Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

4.18
Delayed Data
As of Mar 04
 +0.03 / +0.72%
Today’s Change
2.81
Today|||52-Week Range
8.47
-12.18%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Computer Peripherals
MARKET CAP
$74.7M

Company Description

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops innovative adult stem cell therapeutic products. It currently focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in New York, NY.

Contact Information

Brainstorm Cell Therapeutics, Inc.
605 3rd Avenue
New York New York 10158
P:(646) 666-3188
Investor Relations:

Employees

Shareholders

Individual stakeholders11.47%
Other institutional10.00%
Mutual fund holders0.77%

Top Executives

Anthony S. FiorinoChief Executive Officer
Chaim LebovitsPresident
Uri YablonkaChief Operating Officer
Liat SossoverChief Financial Officer
Yael GothelfVice President-Scientific & Regulatory Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account